RGEN 8-K 2026-10-06

REPLIGEN CORP (RGEN) 8-K dated 2026-10-06 — accession 0001193125-26-415015. This URL is the filing, not the RGEN hub.

REPLIGEN CORP (RGEN) is a medical instruments & supplies company listed on NASDAQ.

REPLIGEN CORP filed a 8-K on 2026-10-06. Accession 0001193125-26-415015.

Cached items: 2.01, 7.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported RGEN revenue for 2025-12-31 was $738.3M. Net income was $48.9M. Revenue was up 16.4% from 2024-12-31 to 2025-12-31. RGEN currently screens at market cap $7.43B.

Not investment advice. The RGEN SEC hub lists recent forms. The stock page is the research view.